Skip to main content
Figure 6 | Molecular Cancer

Figure 6

From: The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1

Figure 6

Combined BC and low dose gemcitabine therapy efficiently suppressed tumor growth and induced tumor cell death in a lung cancer xenograft model. A , A549 cells (2×106) were injected into the flank of 6- to 8-week-old male nude mice to establish a tumor xenograft model. Three weeks later when tumor volumes had reached about 100 mm3, BC or control adenovirus and Tet-off adenovirus (5×106 PFU) were directly injected into tumors, and 10 mg/kg gemcitabine or PBS were administered intraperitoneally. These therapies were performed three times with two days intervals. Tumor volumes were measured every 2 to 3 days for one month. Each experimental group included 5 mice and means ± SDs are plotted. *p < 0.001 and ** p < 0.05 by the Student's t test for differences between tumor volumes between experimental groups. B and C , On day 30 after the last treatment, mice were sacrificed and tumors were extracted. The histogram shows the means ± SDs of tumor weights in each group (n = 5) (B). Tumor sections were analyzed by hematoxylin and eosin staining for histological features, such as, tumor necrosis and apoptosis. Numbers at the top of column indicates magnification (C).

Back to article page